Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Gene Therapy-based Drug market report explains the definition, types, applications, major countries, and major players of the Gene Therapy-based Drug market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Amgen
Biogen
Novartis
Alnylam Pharmaceuticals
Spark Therapeutics
AnGes
SIBIONO
bluebird bio
Akcea Therapeutics
Orchard Therapeutics
Sarepta Therapeutics
Gilead Sciences
Human Stem Cells Institute
Sunway Biotech
By Type:
Viral Gene Delivery System
Non-viral Gene Delivery System
By End-User:
Neurological Diseases
Cancer
Other
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Gene Therapy-based Drug Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Gene Therapy-based Drug Outlook to 2028- Original Forecasts
-
2.2 Gene Therapy-based Drug Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Gene Therapy-based Drug Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Gene Therapy-based Drug Market- Recent Developments
-
6.1 Gene Therapy-based Drug Market News and Developments
-
6.2 Gene Therapy-based Drug Market Deals Landscape
7 Gene Therapy-based Drug Raw Materials and Cost Structure Analysis
-
7.1 Gene Therapy-based Drug Key Raw Materials
-
7.2 Gene Therapy-based Drug Price Trend of Key Raw Materials
-
7.3 Gene Therapy-based Drug Key Suppliers of Raw Materials
-
7.4 Gene Therapy-based Drug Market Concentration Rate of Raw Materials
-
7.5 Gene Therapy-based Drug Cost Structure Analysis
-
7.5.1 Gene Therapy-based Drug Raw Materials Analysis
-
7.5.2 Gene Therapy-based Drug Labor Cost Analysis
-
7.5.3 Gene Therapy-based Drug Manufacturing Expenses Analysis
8 Global Gene Therapy-based Drug Import and Export Analysis (Top 10 Countries)
-
8.1 Global Gene Therapy-based Drug Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Gene Therapy-based Drug Export by Region (Top 10 Countries) (2017-2028)
9 Global Gene Therapy-based Drug Market Outlook by Types and Applications to 2022
-
9.1 Global Gene Therapy-based Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Viral Gene Delivery System Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Non-viral Gene Delivery System Consumption and Growth Rate (2017-2022)
-
9.2 Global Gene Therapy-based Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Neurological Diseases Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Cancer Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Other Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Gene Therapy-based Drug Market Analysis and Outlook till 2022
-
10.1 Global Gene Therapy-based Drug Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Gene Therapy-based Drug Consumption (2017-2022)
-
10.2.2 Canada Gene Therapy-based Drug Consumption (2017-2022)
-
10.2.3 Mexico Gene Therapy-based Drug Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Gene Therapy-based Drug Consumption (2017-2022)
-
10.3.2 UK Gene Therapy-based Drug Consumption (2017-2022)
-
10.3.3 Spain Gene Therapy-based Drug Consumption (2017-2022)
-
10.3.4 Belgium Gene Therapy-based Drug Consumption (2017-2022)
-
10.3.5 France Gene Therapy-based Drug Consumption (2017-2022)
-
10.3.6 Italy Gene Therapy-based Drug Consumption (2017-2022)
-
10.3.7 Denmark Gene Therapy-based Drug Consumption (2017-2022)
-
10.3.8 Finland Gene Therapy-based Drug Consumption (2017-2022)
-
10.3.9 Norway Gene Therapy-based Drug Consumption (2017-2022)
-
10.3.10 Sweden Gene Therapy-based Drug Consumption (2017-2022)
-
10.3.11 Poland Gene Therapy-based Drug Consumption (2017-2022)
-
10.3.12 Russia Gene Therapy-based Drug Consumption (2017-2022)
-
10.3.13 Turkey Gene Therapy-based Drug Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Gene Therapy-based Drug Consumption (2017-2022)
-
10.4.2 Japan Gene Therapy-based Drug Consumption (2017-2022)
-
10.4.3 India Gene Therapy-based Drug Consumption (2017-2022)
-
10.4.4 South Korea Gene Therapy-based Drug Consumption (2017-2022)
-
10.4.5 Pakistan Gene Therapy-based Drug Consumption (2017-2022)
-
10.4.6 Bangladesh Gene Therapy-based Drug Consumption (2017-2022)
-
10.4.7 Indonesia Gene Therapy-based Drug Consumption (2017-2022)
-
10.4.8 Thailand Gene Therapy-based Drug Consumption (2017-2022)
-
10.4.9 Singapore Gene Therapy-based Drug Consumption (2017-2022)
-
10.4.10 Malaysia Gene Therapy-based Drug Consumption (2017-2022)
-
10.4.11 Philippines Gene Therapy-based Drug Consumption (2017-2022)
-
10.4.12 Vietnam Gene Therapy-based Drug Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Gene Therapy-based Drug Consumption (2017-2022)
-
10.5.2 Colombia Gene Therapy-based Drug Consumption (2017-2022)
-
10.5.3 Chile Gene Therapy-based Drug Consumption (2017-2022)
-
10.5.4 Argentina Gene Therapy-based Drug Consumption (2017-2022)
-
10.5.5 Venezuela Gene Therapy-based Drug Consumption (2017-2022)
-
10.5.6 Peru Gene Therapy-based Drug Consumption (2017-2022)
-
10.5.7 Puerto Rico Gene Therapy-based Drug Consumption (2017-2022)
-
10.5.8 Ecuador Gene Therapy-based Drug Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Gene Therapy-based Drug Consumption (2017-2022)
-
10.6.2 Kuwait Gene Therapy-based Drug Consumption (2017-2022)
-
10.6.3 Oman Gene Therapy-based Drug Consumption (2017-2022)
-
10.6.4 Qatar Gene Therapy-based Drug Consumption (2017-2022)
-
10.6.5 Saudi Arabia Gene Therapy-based Drug Consumption (2017-2022)
-
10.6.6 United Arab Emirates Gene Therapy-based Drug Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Gene Therapy-based Drug Consumption (2017-2022)
-
10.7.2 South Africa Gene Therapy-based Drug Consumption (2017-2022)
-
10.7.3 Egypt Gene Therapy-based Drug Consumption (2017-2022)
-
10.7.4 Algeria Gene Therapy-based Drug Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Gene Therapy-based Drug Consumption (2017-2022)
-
10.8.2 New Zealand Gene Therapy-based Drug Consumption (2017-2022)
11 Global Gene Therapy-based Drug Competitive Analysis
-
11.1 Amgen
-
11.1.1 Amgen Company Details
-
11.1.2 Amgen Gene Therapy-based Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Amgen Gene Therapy-based Drug Main Business and Markets Served
-
11.1.4 Amgen Gene Therapy-based Drug Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Biogen
-
11.2.1 Biogen Company Details
-
11.2.2 Biogen Gene Therapy-based Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Biogen Gene Therapy-based Drug Main Business and Markets Served
-
11.2.4 Biogen Gene Therapy-based Drug Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Novartis
-
11.3.1 Novartis Company Details
-
11.3.2 Novartis Gene Therapy-based Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Novartis Gene Therapy-based Drug Main Business and Markets Served
-
11.3.4 Novartis Gene Therapy-based Drug Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Alnylam Pharmaceuticals
-
11.4.1 Alnylam Pharmaceuticals Company Details
-
11.4.2 Alnylam Pharmaceuticals Gene Therapy-based Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Alnylam Pharmaceuticals Gene Therapy-based Drug Main Business and Markets Served
-
11.4.4 Alnylam Pharmaceuticals Gene Therapy-based Drug Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Spark Therapeutics
-
11.5.1 Spark Therapeutics Company Details
-
11.5.2 Spark Therapeutics Gene Therapy-based Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Spark Therapeutics Gene Therapy-based Drug Main Business and Markets Served
-
11.5.4 Spark Therapeutics Gene Therapy-based Drug Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 AnGes
-
11.6.1 AnGes Company Details
-
11.6.2 AnGes Gene Therapy-based Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 AnGes Gene Therapy-based Drug Main Business and Markets Served
-
11.6.4 AnGes Gene Therapy-based Drug Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 SIBIONO
-
11.7.1 SIBIONO Company Details
-
11.7.2 SIBIONO Gene Therapy-based Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 SIBIONO Gene Therapy-based Drug Main Business and Markets Served
-
11.7.4 SIBIONO Gene Therapy-based Drug Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 bluebird bio
-
11.8.1 bluebird bio Company Details
-
11.8.2 bluebird bio Gene Therapy-based Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 bluebird bio Gene Therapy-based Drug Main Business and Markets Served
-
11.8.4 bluebird bio Gene Therapy-based Drug Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Akcea Therapeutics
-
11.9.1 Akcea Therapeutics Company Details
-
11.9.2 Akcea Therapeutics Gene Therapy-based Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Akcea Therapeutics Gene Therapy-based Drug Main Business and Markets Served
-
11.9.4 Akcea Therapeutics Gene Therapy-based Drug Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Orchard Therapeutics
-
11.10.1 Orchard Therapeutics Company Details
-
11.10.2 Orchard Therapeutics Gene Therapy-based Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Orchard Therapeutics Gene Therapy-based Drug Main Business and Markets Served
-
11.10.4 Orchard Therapeutics Gene Therapy-based Drug Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Sarepta Therapeutics
-
11.11.1 Sarepta Therapeutics Company Details
-
11.11.2 Sarepta Therapeutics Gene Therapy-based Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Sarepta Therapeutics Gene Therapy-based Drug Main Business and Markets Served
-
11.11.4 Sarepta Therapeutics Gene Therapy-based Drug Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 Gilead Sciences
-
11.12.1 Gilead Sciences Company Details
-
11.12.2 Gilead Sciences Gene Therapy-based Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 Gilead Sciences Gene Therapy-based Drug Main Business and Markets Served
-
11.12.4 Gilead Sciences Gene Therapy-based Drug Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 Human Stem Cells Institute
-
11.13.1 Human Stem Cells Institute Company Details
-
11.13.2 Human Stem Cells Institute Gene Therapy-based Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 Human Stem Cells Institute Gene Therapy-based Drug Main Business and Markets Served
-
11.13.4 Human Stem Cells Institute Gene Therapy-based Drug Product Portfolio
-
11.13.5 Recent Research and Development Strategies
-
11.14 Sunway Biotech
-
11.14.1 Sunway Biotech Company Details
-
11.14.2 Sunway Biotech Gene Therapy-based Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.14.3 Sunway Biotech Gene Therapy-based Drug Main Business and Markets Served
-
11.14.4 Sunway Biotech Gene Therapy-based Drug Product Portfolio
-
11.14.5 Recent Research and Development Strategies
12 Global Gene Therapy-based Drug Market Outlook by Types and Applications to 2028
-
12.1 Global Gene Therapy-based Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Viral Gene Delivery System Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Non-viral Gene Delivery System Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Gene Therapy-based Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Neurological Diseases Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Cancer Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Gene Therapy-based Drug Market Analysis and Outlook to 2028
-
13.1 Global Gene Therapy-based Drug Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Gene Therapy-based Drug Consumption Forecast (2022-2028)
-
13.2.2 Canada Gene Therapy-based Drug Consumption Forecast (2022-2028)
-
13.2.3 Mexico Gene Therapy-based Drug Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Gene Therapy-based Drug Consumption Forecast (2022-2028)
-
13.3.2 UK Gene Therapy-based Drug Consumption Forecast (2022-2028)
-
13.3.3 Spain Gene Therapy-based Drug Consumption Forecast (2022-2028)
-
13.3.4 Belgium Gene Therapy-based Drug Consumption Forecast (2022-2028)
-
13.3.5 France Gene Therapy-based Drug Consumption Forecast (2022-2028)
-
13.3.6 Italy Gene Therapy-based Drug Consumption Forecast (2022-2028)
-
13.3.7 Denmark Gene Therapy-based Drug Consumption Forecast (2022-2028)
-
13.3.8 Finland Gene Therapy-based Drug Consumption Forecast (2022-2028)
-
13.3.9 Norway Gene Therapy-based Drug Consumption Forecast (2022-2028)
-
13.3.10 Sweden Gene Therapy-based Drug Consumption Forecast (2022-2028)
-
13.3.11 Poland Gene Therapy-based Drug Consumption Forecast (2022-2028)
-
13.3.12 Russia Gene Therapy-based Drug Consumption Forecast (2022-2028)
-
13.3.13 Turkey Gene Therapy-based Drug Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Gene Therapy-based Drug Consumption Forecast (2022-2028)
-
13.4.2 Japan Gene Therapy-based Drug Consumption Forecast (2022-2028)
-
13.4.3 India Gene Therapy-based Drug Consumption Forecast (2022-2028)
-
13.4.4 South Korea Gene Therapy-based Drug Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Gene Therapy-based Drug Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Gene Therapy-based Drug Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Gene Therapy-based Drug Consumption Forecast (2022-2028)
-
13.4.8 Thailand Gene Therapy-based Drug Consumption Forecast (2022-2028)
-
13.4.9 Singapore Gene Therapy-based Drug Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Gene Therapy-based Drug Consumption Forecast (2022-2028)
-
13.4.11 Philippines Gene Therapy-based Drug Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Gene Therapy-based Drug Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Gene Therapy-based Drug Consumption Forecast (2022-2028)
-
13.5.2 Colombia Gene Therapy-based Drug Consumption Forecast (2022-2028)
-
13.5.3 Chile Gene Therapy-based Drug Consumption Forecast (2022-2028)
-
13.5.4 Argentina Gene Therapy-based Drug Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Gene Therapy-based Drug Consumption Forecast (2022-2028)
-
13.5.6 Peru Gene Therapy-based Drug Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Gene Therapy-based Drug Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Gene Therapy-based Drug Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Gene Therapy-based Drug Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Gene Therapy-based Drug Consumption Forecast (2022-2028)
-
13.6.3 Oman Gene Therapy-based Drug Consumption Forecast (2022-2028)
-
13.6.4 Qatar Gene Therapy-based Drug Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Gene Therapy-based Drug Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Gene Therapy-based Drug Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Gene Therapy-based Drug Consumption Forecast (2022-2028)
-
13.7.2 South Africa Gene Therapy-based Drug Consumption Forecast (2022-2028)
-
13.7.3 Egypt Gene Therapy-based Drug Consumption Forecast (2022-2028)
-
13.7.4 Algeria Gene Therapy-based Drug Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Gene Therapy-based Drug Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Gene Therapy-based Drug Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Gene Therapy-based Drug
-
Figure of Gene Therapy-based Drug Picture
-
Table Global Gene Therapy-based Drug Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Gene Therapy-based Drug Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Viral Gene Delivery System Consumption and Growth Rate (2017-2022)
-
Figure Global Non-viral Gene Delivery System Consumption and Growth Rate (2017-2022)
-
Figure Global Neurological Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Gene Therapy-based Drug Consumption by Country (2017-2022)
-
Table North America Gene Therapy-based Drug Consumption by Country (2017-2022)
-
Figure United States Gene Therapy-based Drug Consumption and Growth Rate (2017-2022)
-
Figure Canada Gene Therapy-based Drug Consumption and Growth Rate (2017-2022)
-
Figure Mexico Gene Therapy-based Drug Consumption and Growth Rate (2017-2022)
-
Table Europe Gene Therapy-based Drug Consumption by Country (2017-2022)
-
Figure Germany Gene Therapy-based Drug Consumption and Growth Rate (2017-2022)
-
Figure UK Gene Therapy-based Drug Consumption and Growth Rate (2017-2022)
-
Figure Spain Gene Therapy-based Drug Consumption and Growth Rate (2017-2022)
-
Figure Belgium Gene Therapy-based Drug Consumption and Growth Rate (2017-2022)
-
Figure France Gene Therapy-based Drug Consumption and Growth Rate (2017-2022)
-
Figure Italy Gene Therapy-based Drug Consumption and Growth Rate (2017-2022)
-
Figure Denmark Gene Therapy-based Drug Consumption and Growth Rate (2017-2022)
-
Figure Finland Gene Therapy-based Drug Consumption and Growth Rate (2017-2022)
-
Figure Norway Gene Therapy-based Drug Consumption and Growth Rate (2017-2022)
-
Figure Sweden Gene Therapy-based Drug Consumption and Growth Rate (2017-2022)
-
Figure Poland Gene Therapy-based Drug Consumption and Growth Rate (2017-2022)
-
Figure Russia Gene Therapy-based Drug Consumption and Growth Rate (2017-2022)
-
Figure Turkey Gene Therapy-based Drug Consumption and Growth Rate (2017-2022)
-
Table APAC Gene Therapy-based Drug Consumption by Country (2017-2022)
-
Figure China Gene Therapy-based Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan Gene Therapy-based Drug Consumption and Growth Rate (2017-2022)
-
Figure India Gene Therapy-based Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea Gene Therapy-based Drug Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Gene Therapy-based Drug Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Gene Therapy-based Drug Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Gene Therapy-based Drug Consumption and Growth Rate (2017-2022)
-
Figure Thailand Gene Therapy-based Drug Consumption and Growth Rate (2017-2022)
-
Figure Singapore Gene Therapy-based Drug Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Gene Therapy-based Drug Consumption and Growth Rate (2017-2022)
-
Figure Philippines Gene Therapy-based Drug Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Gene Therapy-based Drug Consumption and Growth Rate (2017-2022)
-
Table South America Gene Therapy-based Drug Consumption by Country (2017-2022)
-
Figure Brazil Gene Therapy-based Drug Consumption and Growth Rate (2017-2022)
-
Figure Colombia Gene Therapy-based Drug Consumption and Growth Rate (2017-2022)
-
Figure Chile Gene Therapy-based Drug Consumption and Growth Rate (2017-2022)
-
Figure Argentina Gene Therapy-based Drug Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Gene Therapy-based Drug Consumption and Growth Rate (2017-2022)
-
Figure Peru Gene Therapy-based Drug Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Gene Therapy-based Drug Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Gene Therapy-based Drug Consumption and Growth Rate (2017-2022)
-
Table GCC Gene Therapy-based Drug Consumption by Country (2017-2022)
-
Figure Bahrain Gene Therapy-based Drug Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Gene Therapy-based Drug Consumption and Growth Rate (2017-2022)
-
Figure Oman Gene Therapy-based Drug Consumption and Growth Rate (2017-2022)
-
Figure Qatar Gene Therapy-based Drug Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Gene Therapy-based Drug Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Gene Therapy-based Drug Consumption and Growth Rate (2017-2022)
-
Table Africa Gene Therapy-based Drug Consumption by Country (2017-2022)
-
Figure Nigeria Gene Therapy-based Drug Consumption and Growth Rate (2017-2022)
-
Figure South Africa Gene Therapy-based Drug Consumption and Growth Rate (2017-2022)
-
Figure Egypt Gene Therapy-based Drug Consumption and Growth Rate (2017-2022)
-
Figure Algeria Gene Therapy-based Drug Consumption and Growth Rate (2017-2022)
-
Table Oceania Gene Therapy-based Drug Consumption by Country (2017-2022)
-
Figure Australia Gene Therapy-based Drug Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Gene Therapy-based Drug Consumption and Growth Rate (2017-2022)
-
Table Amgen Company Details
-
Table Amgen Gene Therapy-based Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Gene Therapy-based Drug Main Business and Markets Served
-
Table Amgen Gene Therapy-based Drug Product Portfolio
-
Table Biogen Company Details
-
Table Biogen Gene Therapy-based Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biogen Gene Therapy-based Drug Main Business and Markets Served
-
Table Biogen Gene Therapy-based Drug Product Portfolio
-
Table Novartis Company Details
-
Table Novartis Gene Therapy-based Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Gene Therapy-based Drug Main Business and Markets Served
-
Table Novartis Gene Therapy-based Drug Product Portfolio
-
Table Alnylam Pharmaceuticals Company Details
-
Table Alnylam Pharmaceuticals Gene Therapy-based Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Alnylam Pharmaceuticals Gene Therapy-based Drug Main Business and Markets Served
-
Table Alnylam Pharmaceuticals Gene Therapy-based Drug Product Portfolio
-
Table Spark Therapeutics Company Details
-
Table Spark Therapeutics Gene Therapy-based Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Spark Therapeutics Gene Therapy-based Drug Main Business and Markets Served
-
Table Spark Therapeutics Gene Therapy-based Drug Product Portfolio
-
Table AnGes Company Details
-
Table AnGes Gene Therapy-based Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table AnGes Gene Therapy-based Drug Main Business and Markets Served
-
Table AnGes Gene Therapy-based Drug Product Portfolio
-
Table SIBIONO Company Details
-
Table SIBIONO Gene Therapy-based Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table SIBIONO Gene Therapy-based Drug Main Business and Markets Served
-
Table SIBIONO Gene Therapy-based Drug Product Portfolio
-
Table bluebird bio Company Details
-
Table bluebird bio Gene Therapy-based Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table bluebird bio Gene Therapy-based Drug Main Business and Markets Served
-
Table bluebird bio Gene Therapy-based Drug Product Portfolio
-
Table Akcea Therapeutics Company Details
-
Table Akcea Therapeutics Gene Therapy-based Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Akcea Therapeutics Gene Therapy-based Drug Main Business and Markets Served
-
Table Akcea Therapeutics Gene Therapy-based Drug Product Portfolio
-
Table Orchard Therapeutics Company Details
-
Table Orchard Therapeutics Gene Therapy-based Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Orchard Therapeutics Gene Therapy-based Drug Main Business and Markets Served
-
Table Orchard Therapeutics Gene Therapy-based Drug Product Portfolio
-
Table Sarepta Therapeutics Company Details
-
Table Sarepta Therapeutics Gene Therapy-based Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sarepta Therapeutics Gene Therapy-based Drug Main Business and Markets Served
-
Table Sarepta Therapeutics Gene Therapy-based Drug Product Portfolio
-
Table Gilead Sciences Company Details
-
Table Gilead Sciences Gene Therapy-based Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gilead Sciences Gene Therapy-based Drug Main Business and Markets Served
-
Table Gilead Sciences Gene Therapy-based Drug Product Portfolio
-
Table Human Stem Cells Institute Company Details
-
Table Human Stem Cells Institute Gene Therapy-based Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Human Stem Cells Institute Gene Therapy-based Drug Main Business and Markets Served
-
Table Human Stem Cells Institute Gene Therapy-based Drug Product Portfolio
-
Table Sunway Biotech Company Details
-
Table Sunway Biotech Gene Therapy-based Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sunway Biotech Gene Therapy-based Drug Main Business and Markets Served
-
Table Sunway Biotech Gene Therapy-based Drug Product Portfolio
-
Figure Global Viral Gene Delivery System Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Non-viral Gene Delivery System Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Neurological Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Gene Therapy-based Drug Consumption Forecast by Country (2022-2028)
-
Table North America Gene Therapy-based Drug Consumption Forecast by Country (2022-2028)
-
Figure United States Gene Therapy-based Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Gene Therapy-based Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Gene Therapy-based Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Gene Therapy-based Drug Consumption Forecast by Country (2022-2028)
-
Figure Germany Gene Therapy-based Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Gene Therapy-based Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Gene Therapy-based Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Gene Therapy-based Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Gene Therapy-based Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Gene Therapy-based Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Gene Therapy-based Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Gene Therapy-based Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Gene Therapy-based Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Gene Therapy-based Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Gene Therapy-based Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Gene Therapy-based Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Gene Therapy-based Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Gene Therapy-based Drug Consumption Forecast by Country (2022-2028)
-
Figure China Gene Therapy-based Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Gene Therapy-based Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Gene Therapy-based Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Gene Therapy-based Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Gene Therapy-based Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Gene Therapy-based Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Gene Therapy-based Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Gene Therapy-based Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Gene Therapy-based Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Gene Therapy-based Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Gene Therapy-based Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Gene Therapy-based Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Gene Therapy-based Drug Consumption Forecast by Country (2022-2028)
-
Figure Brazil Gene Therapy-based Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Gene Therapy-based Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Gene Therapy-based Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Gene Therapy-based Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Gene Therapy-based Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Gene Therapy-based Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Gene Therapy-based Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Gene Therapy-based Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Gene Therapy-based Drug Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Gene Therapy-based Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Gene Therapy-based Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Gene Therapy-based Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Gene Therapy-based Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Gene Therapy-based Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Gene Therapy-based Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Gene Therapy-based Drug Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Gene Therapy-based Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Gene Therapy-based Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Gene Therapy-based Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Gene Therapy-based Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Gene Therapy-based Drug Consumption Forecast by Country (2022-2028)
-
Figure Australia Gene Therapy-based Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Gene Therapy-based Drug Consumption Forecast and Growth Rate (2022-2028)
-
